Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Review Article Volume 4 Issue 6

HPV Test As Primary Screening Tool

Priya Ganesh Kumar*

Department of Preventive Oncology, Medical Director of Sainiwas Healthcare, India

*Corresponding Author: Priya Ganesh Kumar, Department of Preventive Oncology, Medical Director of Sainiwas Healthcare, India.

Received: April 22, 2022; Published: May 06, 2022


WHO Mission statement of Cervical cancer Elimination by 2030 has been a historic moment and has created an impactful global awareness regarding this deadly disease. The triple formula of 90-70-90 has been designed to have a 30% reduction in mortality from cervical cancer to be achieved by 2030. The goal of Cervical cancer elimination is to bring down the cases of cervical cancer below 4 per 100,000 woman. To achieve this goal the targets laid down is 90% coverage of girls fully vaccinated with HPV Vaccine by 15 years of age, 70% of women screened with an HPV test at 35 and 45 years of age and all managed properly, 90% of women identified with preinvasive disease receive adequate treatment and follow up. It is now an established fact that cervical cancer is caused by persistent infection with high-risk HPV strains. 4 out of 5 women in our country is affected with HPV, HPV being a sexually transmitted virus. Persistent high risk (HR) HPV is necessary for development of precursor lesions and cervical cancer. The major steps in cervical carcinogenesis include HPV infection, HPV persistence for a certain period of time, progression to precancer and invasion

Keywords:HPV; Cervical Cancer; Screening


  1. Lancet Oncology12 (2018): 89-306.
  2. Peter A. “Medscape Global Prevalence of high risk HPV in women with normal cytology” (2020).
  3. Bruni L and Diaz M. “Meta-analysis of 1 million women with normal cytological findings”. The Journal of Infectious Diseases 12 (2015): 1789-1799.
  4. PE Gravit. “The known unknown of HPV natural history”. Journal of Clinical Investigation12 (2011): 4593-4599.
  5. Neerja Bhatla., et al. “Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from FOGSI HTTPS”. 46.2 (2020): 201-214.
  6. Sankarnarayanan R., et al. “HPV screening for cervical cancer in rural India”. The New England Journal of Medicine 360 (2009): 1385-1394.
  7. Wright TC and Stoler MH. “The Athena human papillomavirus study”. American Journal of Obstetrics and Gynecology 206 (2012): 46-e1.


Citation: Priya Ganesh Kumar. “HPV Test As Primary Screening Tool". Acta Scientific Women's Health 4.6 (2022): 31-34.


Copyright: © 2022 Priya Ganesh Kumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US